Ultrasonography for Breast Cancer

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA
Breast CancerUltrasonography - Procedure
What conditions do you have?

Study Summary

This trial will compare automated breast ultrasound (ABUS) to handheld ultrasound (HHUS) for screening women who have had breast reconstruction after breast cancer.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 1 year

Up to 1 year
Detection of the residual tissue (i.e., artifact) in reconstructed nipple sparing mastectomy (NSM) and skin sparing mastectomy (SSM) patients by automated breast ultrasound (ABUS) and handheld ultrasound (HHUS)

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Screening (automated breast ultrasound, handheld ultrasound)
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Ultrasonography · No Placebo Group · N/A

Screening (automated breast ultrasound, handheld ultrasound)Experimental Group · 2 Interventions: Ultrasonography, Automated Breast Ultrasound · Intervention Types: Procedure, Procedure
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
416 Previous Clinical Trials
136,784 Total Patients Enrolled
5 Trials studying Breast Cancer
607 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a woman.

Frequently Asked Questions

What is the present enrollment number for this research project?

"Affirmative. Per information hosted on clinicaltrials.gov, this investigation is currently accepting applications from potential participants. This trial was initially published on November 18th 2022 and recently revised on the 21st of that same month. A total of 30 individuals need to be enrolled at one site for the study's completion." - Anonymous Online Contributor

Unverified Answer

Are there still open slots for participants in this clinical study?

"Indeed, clinicaltrials.gov indicates that this research is still open for participants. The trial was launched on November 18th 2022 and has seen recent activity on the 21st of the same month. 30 individuals are being sought to join this single-site study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.